[So-called antiphospholipid antibodies and infertility: biological data].
Recurrent early and late foetal losses are common problems found in women with antiphospholipid syndrome, with therapeutic implication and improvement of the prognosis for the next pregnancies with antithrombotic therapy. After these results, some groups propose to extend the antiphospholipid investigations to infertility and failure of in vitro fertilization embryo transfer, but actually without demonstration of a real utility in the management of these women.